1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: CDR0000447204, P30CA016058, OHSU-HEM-05011-L, OHSU-210, NCT00245037
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 70 and under Sponsor: Other Protocol IDs: BCM-H-19386, BCM-FAB, H 19386, NCT00625144
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Any age Sponsor: NCI, Other Protocol IDs: 2226.00, NCI-2010-00107, P01CA078902, P01CA018029, FHCRC-2226.00, IR-6884, NCT00867529
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MU9230, NCT00899353
|
|
5.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: 2007LS022, MT2006-01, 0701M00303, UMN-2007LS022, UMN-MT2006-01, UMN-0701M00303, UMN-12559, UMN-6220-04, NCT00602693
|
|
6.
|
Phase: No phase specified Type: Treatment Status: Active Age: Under 70 Sponsor: NCI, Other Protocol IDs: CDR0000518230, P30CA022453, WSU-2006-059, WSU-112506MP2F, NCT00423826
|